Live Breaking News & Updates on Secretary Health Aamir Ashraf Khwaja

Stay updated with breaking news from Secretary health aamir ashraf khwaja. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Volunteers invited to participate in vaccine trials

Volunteers invited to participate in vaccine trials
Islamabad
April 24, 2021
Islamabad : The Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU) is the first public sector university in Islamabad to become a DRAP-approved site for Phase III clinical trials of COVID-19 vaccine. SZABMU-PIMS is now becoming part of a multicentre phase III study for COVID-19 vaccine ZF2001. These trials have been approved by National Bioethics Committee (NBC) Pakistan and Drug Regulatory Authority of Pakistan (DRAP).
Prof. Dr. Tanwir Khaliq, Vice Chancellor of SZAMBU, expressed these views during a briefing given to Secretary Health Aamir Ashraf Khwaja when he visited the university here on Friday. ....

Tanwir Khaliq , Shaheed Zulfiqar Ali Bhutto Medical University , National Bioethics Committee , Drug Regulatory Authority Of Pakistan , Anhui Zhifei Longcom Biopharmaceutical Co Ltd , Health Aamir Ashraf Khwaja , Drug Regulatory Authority , Vice Chancellor , Secretary Health Aamir Ashraf Khwaja , Chinese Academy , தன்வீர் க்யாலிக் , ஷாஹீத் ஸல்ஃபிகர் அலி பூட்டோ மருத்துவ பல்கலைக்கழகம் , தேசிய உயிர்வேதியியல் குழு , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , மருந்து ஒழுங்குமுறை அதிகாரம் , துணை அதிபர் , சீன கலைக்கழகம் ,

Federal health secretary visits SZABMU

Daily Times
Federal Secretary Health Aamir Ashraf Khwaja visited Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU), PIMS.
He was briefed by Prof. Dr. Tanwir Khaliq, Vice Chancellor, that SZABMU is the public sector university in Islamabad to become a DRAP approved site for Phase III clinical trials of Covid-19 vaccine. SZABMU-PIMS is now becoming a part of a multicentre phase III study for COVID-19 vaccine ZF2001. These trials have been approved by National Bioethics Committee (NBC) Pakistan and Drug Regulatory Authority of Pakistan (DRAP).
Due to the global COVID-19 pandemic, medical researchers all over the world are rushing into the research and development of vaccines. ZF2001 vaccine is co-developed by The Institute of Microbiology of the Chinese Academy of Sciences (IMCAS) and Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. It is a protein subunit based vaccine targeting different variants of COVID-19 as well. It is expected to prevent respiratory diseases ....

Tanwir Khaliq , Shaheed Zulfiqar Ali Bhutto Medical University , National Bioethics Committee , Drug Regulatory Authority Of Pakistan , Anhui Zhifei Longcom Biopharmaceutical Co Ltd , Health Aamir Ashraf Khwaja , Secretary Health Aamir Ashraf Khwaja , Vice Chancellor , Drug Regulatory Authority , Chinese Academy , தன்வீர் க்யாலிக் , ஷாஹீத் ஸல்ஃபிகர் அலி பூட்டோ மருத்துவ பல்கலைக்கழகம் , தேசிய உயிர்வேதியியல் குழு , மருந்து ஒழுங்குமுறை அதிகாரம் ஆஃப் பாக்கிஸ்தான் , துணை அதிபர் , மருந்து ஒழுங்குமுறை அதிகாரம் , சீன கலைக்கழகம் ,